Raynaud's phenomenon-an update on diagnosis, classification and management

John D Pauling, Michael Hughes, Janet E Pope

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Abstract: Raynaud’s phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. RP is a clinical diagnosis. The typically episodic nature of RP has resulted in a reliance upon patient self-report for diagnosis. The term ‘primary RP’ is generally applied when no underlying pathology can be demonstrated. Whilst ‘primary RP’ is currently considered a distinct disorder, there is evidence that the term may comprise several entities that include a functional vasospastic disorder, a physiologically appropriate thermoregulatory response, subclinical atherosclerosis and ‘cold intolerance’. Optimal management may differ depending on cause. The term ‘secondary RP’ encompasses a broad range of rheumatological, haematological, endocrinological and vascular pathology. RP can range from relatively benign but intrusive vasospasm, to the progressive obliterative microangiopathy of systemic sclerosis (SSc), in which severe digital ischaemia can threaten tissue viability. SSc has formed the focus of much of the research into RP but, consistent with most medical symptom complexes, the aetiopathogenesis of RP varies greatly dependent on cause. Vasospasm within the digital macro- and microvasculature occurs in SSc, but digital ischaemia is further compounded by a progressive obliterative microangiopathy. Recent work exploring the patient experience of SSc-RP is challenging the ‘episodic’ paradigm of ‘Raynaud’s’, with important implications for clinical trials utilising diary-based patient-reported outcome instruments for assessing Raynaud’s symptoms. This review shall examine the causes, pathogenesis, clinical features, classification and management of RP. A practical approach to the evaluation and management of RP is outlined, highlighting important knowledge gaps and unmet research needs where applicable.

Original languageEnglish
Pages (from-to)3317-3330
Number of pages14
JournalClinical Rheumatology
Volume38
Issue number12
Early online date16 Aug 2019
DOIs
Publication statusPublished - 1 Dec 2019

Keywords

  • Assessment
  • Classification
  • Management
  • Pathogenesis
  • Raynaud’s phenomenon
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Raynaud's phenomenon-an update on diagnosis, classification and management. / Pauling, John D; Hughes, Michael; Pope, Janet E.

In: Clinical Rheumatology, Vol. 38, No. 12, 01.12.2019, p. 3317-3330.

Research output: Contribution to journalArticle

Pauling, John D ; Hughes, Michael ; Pope, Janet E. / Raynaud's phenomenon-an update on diagnosis, classification and management. In: Clinical Rheumatology. 2019 ; Vol. 38, No. 12. pp. 3317-3330.
@article{b260da67184d4749b6627544740b84e4,
title = "Raynaud's phenomenon-an update on diagnosis, classification and management",
abstract = "Abstract: Raynaud’s phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. RP is a clinical diagnosis. The typically episodic nature of RP has resulted in a reliance upon patient self-report for diagnosis. The term ‘primary RP’ is generally applied when no underlying pathology can be demonstrated. Whilst ‘primary RP’ is currently considered a distinct disorder, there is evidence that the term may comprise several entities that include a functional vasospastic disorder, a physiologically appropriate thermoregulatory response, subclinical atherosclerosis and ‘cold intolerance’. Optimal management may differ depending on cause. The term ‘secondary RP’ encompasses a broad range of rheumatological, haematological, endocrinological and vascular pathology. RP can range from relatively benign but intrusive vasospasm, to the progressive obliterative microangiopathy of systemic sclerosis (SSc), in which severe digital ischaemia can threaten tissue viability. SSc has formed the focus of much of the research into RP but, consistent with most medical symptom complexes, the aetiopathogenesis of RP varies greatly dependent on cause. Vasospasm within the digital macro- and microvasculature occurs in SSc, but digital ischaemia is further compounded by a progressive obliterative microangiopathy. Recent work exploring the patient experience of SSc-RP is challenging the ‘episodic’ paradigm of ‘Raynaud’s’, with important implications for clinical trials utilising diary-based patient-reported outcome instruments for assessing Raynaud’s symptoms. This review shall examine the causes, pathogenesis, clinical features, classification and management of RP. A practical approach to the evaluation and management of RP is outlined, highlighting important knowledge gaps and unmet research needs where applicable.",
keywords = "Assessment, Classification, Management, Pathogenesis, Raynaud’s phenomenon, Systemic sclerosis",
author = "Pauling, {John D} and Michael Hughes and Pope, {Janet E}",
year = "2019",
month = "12",
day = "1",
doi = "10.1007/s10067-019-04745-5",
language = "English",
volume = "38",
pages = "3317--3330",
journal = "Clinical Rheumatology",
issn = "1434-9949",
publisher = "Springer London",
number = "12",

}

TY - JOUR

T1 - Raynaud's phenomenon-an update on diagnosis, classification and management

AU - Pauling, John D

AU - Hughes, Michael

AU - Pope, Janet E

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Abstract: Raynaud’s phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. RP is a clinical diagnosis. The typically episodic nature of RP has resulted in a reliance upon patient self-report for diagnosis. The term ‘primary RP’ is generally applied when no underlying pathology can be demonstrated. Whilst ‘primary RP’ is currently considered a distinct disorder, there is evidence that the term may comprise several entities that include a functional vasospastic disorder, a physiologically appropriate thermoregulatory response, subclinical atherosclerosis and ‘cold intolerance’. Optimal management may differ depending on cause. The term ‘secondary RP’ encompasses a broad range of rheumatological, haematological, endocrinological and vascular pathology. RP can range from relatively benign but intrusive vasospasm, to the progressive obliterative microangiopathy of systemic sclerosis (SSc), in which severe digital ischaemia can threaten tissue viability. SSc has formed the focus of much of the research into RP but, consistent with most medical symptom complexes, the aetiopathogenesis of RP varies greatly dependent on cause. Vasospasm within the digital macro- and microvasculature occurs in SSc, but digital ischaemia is further compounded by a progressive obliterative microangiopathy. Recent work exploring the patient experience of SSc-RP is challenging the ‘episodic’ paradigm of ‘Raynaud’s’, with important implications for clinical trials utilising diary-based patient-reported outcome instruments for assessing Raynaud’s symptoms. This review shall examine the causes, pathogenesis, clinical features, classification and management of RP. A practical approach to the evaluation and management of RP is outlined, highlighting important knowledge gaps and unmet research needs where applicable.

AB - Abstract: Raynaud’s phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. RP is a clinical diagnosis. The typically episodic nature of RP has resulted in a reliance upon patient self-report for diagnosis. The term ‘primary RP’ is generally applied when no underlying pathology can be demonstrated. Whilst ‘primary RP’ is currently considered a distinct disorder, there is evidence that the term may comprise several entities that include a functional vasospastic disorder, a physiologically appropriate thermoregulatory response, subclinical atherosclerosis and ‘cold intolerance’. Optimal management may differ depending on cause. The term ‘secondary RP’ encompasses a broad range of rheumatological, haematological, endocrinological and vascular pathology. RP can range from relatively benign but intrusive vasospasm, to the progressive obliterative microangiopathy of systemic sclerosis (SSc), in which severe digital ischaemia can threaten tissue viability. SSc has formed the focus of much of the research into RP but, consistent with most medical symptom complexes, the aetiopathogenesis of RP varies greatly dependent on cause. Vasospasm within the digital macro- and microvasculature occurs in SSc, but digital ischaemia is further compounded by a progressive obliterative microangiopathy. Recent work exploring the patient experience of SSc-RP is challenging the ‘episodic’ paradigm of ‘Raynaud’s’, with important implications for clinical trials utilising diary-based patient-reported outcome instruments for assessing Raynaud’s symptoms. This review shall examine the causes, pathogenesis, clinical features, classification and management of RP. A practical approach to the evaluation and management of RP is outlined, highlighting important knowledge gaps and unmet research needs where applicable.

KW - Assessment

KW - Classification

KW - Management

KW - Pathogenesis

KW - Raynaud’s phenomenon

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85071001547&partnerID=8YFLogxK

U2 - 10.1007/s10067-019-04745-5

DO - 10.1007/s10067-019-04745-5

M3 - Article

VL - 38

SP - 3317

EP - 3330

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 1434-9949

IS - 12

ER -